AI companies often make bold promises about revolutionizing healthcare, claiming breakthroughs in scientific discovery and medicine development. Yet, the true measure of success is whether these AI technologies have been proven to work in humans, creating life-saving treatments. Unfortunately, most have yet to meet this standard. Real progress in healthcare demands extensive clinical trials, rigorous testing, and years of effort. Leading AI healthcare companies like Insilico Medicine, Recursion, and Owkin are closing the gap by advancing AI-driven discoveries through clinical trials and training AI models on authentic patient data. This approach fosters a continuous improvement cycle where AI performance is refined through real-world feedback, ultimately benefiting patients. While the excitement around AI’s potential is justified, only the AI that withstands the challenges of clinical reality will truly transform medicine.
Back
